I27 |
|
Other pulmonary heart diseases  |
| |
I27.0 |
 |
Primary pulmonary hypertension |
| |
Heritable pulmonary arterial hypertension | Idiopathic pulmonary arterial hypertension | Primary group 1 pulmonary hypertension | Primary pulmonary arterial hypertension |
Excludes1 |
persistent pulmonary hypertension of newborn (P29.30) pulmonary hypertension NOS (I27.20) secondary pulmonary arterial hypertension (I27.21) secondary pulmonary hypertension (I27.29)
|
|
|
| |
I27.1 |
|
Kyphoscoliotic heart disease |
|
| |
I27.2 |
 |
Other secondary pulmonary hypertension |
| |
CodeAlso |
associated underlying condition
|
Excludes1 |
Eisenmenger's syndrome (I27.83)
|
|
| |
I27.20 |
 |
Pulmonary hypertension, unspecified |
| |
Pulmonary hypertension NOS |
|
| | |
I27.21 |
 |
Secondary pulmonary arterial hypertension |
| |
(Associated) (drug-induced) (toxin-induced) pulmonary arterial hypertension NOS | (Associated) (drug-induced) (toxin-induced) (secondary) group 1 pulmonary hypertension |
CodeAlso |
associated conditions if applicable, or adverse effects of drugs or toxins, such as: adverse effect of appetite depressants (T50.5X5) congenital heart disease (Q20-Q28) human immunodeficiency virus [HIV] disease (B20) polymyositis (M33.2-) portal hypertension (K76.6) rheumatoid arthritis (M05.-) schistosomiasis (B65.-) Sjögren syndrome (M35.0-) systemic sclerosis (M34.-)
|
|
| | |
I27.22 |
 |
Pulmonary hypertension due to left heart disease |
| |
Group 2 pulmonary hypertension |
CodeAlso |
associated left heart disease, if known, such as: multiple valve disease (I08.-) rheumatic mitral valve diseases (I05.-) rheumatic aortic valve diseases (I06.-)
|
|
| | |
I27.23 |
 |
Pulmonary hypertension due to lung diseases and hypoxia |
| |
Group 3 pulmonary hypertension |
CodeAlso |
associated lung disease, if known, such as: bronchiectasis (J47.-) cystic fibrosis with pulmonary manifestations (E84.0) interstitial lung disease (J84.-) pleural effusion (J90) sleep apnea (G47.3-)
|
|
| | |
I27.24 |
 |
Chronic thromboembolic pulmonary hypertension |
| |
Group 4 pulmonary hypertension |
CodeAlso |
associated pulmonary embolism, if applicable (I26.-, I27.82)
|
|
| | |
I27.29 |
 |
Other secondary pulmonary hypertension |
| |
Group 5 pulmonary hypertension | Pulmonary hypertension with unclear multifactorial mechanisms | Pulmonary hypertension due to hematologic disorders | Pulmonary hypertension due to metabolic disorders | Pulmonary hypertension due to other systemic disorders |
CodeAlso |
other associated disorders, if known, such as: chronic myeloid leukemia (C92.10-C92.22) essential thrombocythemia (D47.3) Gaucher disease (E75.22) hypertensive chronic kidney disease with end stage renal disease (I12.0, I13.11, I13.2) hyperthyroidism (E05.-) hypothyroidism (E00-E03) polycythemia vera (D45) sarcoidosis (D86.-)
|
|
| |
| |
I27.8 |
|
Other specified pulmonary heart diseases |
| |
I27.81 |
 |
Cor pulmonale (chronic) |
| |
Cor pulmonale NOS |
CodeAlso |
, if applicable, right heart failure (I50.81-)
|
Excludes1 |
acute cor pulmonale (I26.0-)
|
|
| | |
I27.82 |
 |
Chronic pulmonary embolism |
| |
UseAdditionalCode |
code, if applicable, for associated long-term (current) use of anticoagulants (Z79.01)
|
Excludes1 |
personal history of pulmonary embolism (Z86.711)
|
|
| | |
I27.83 |
 |
Eisenmenger's syndrome |
| |
Eisenmenger's complex | (Irreversible) Eisenmenger's disease | Pulmonary hypertension with right to left shunt related to congenital heart disease |
CodeAlso |
underlying heart defect, if known, such as: atrial septal defect (Q21.1-) Eisenmenger's defect (Q21.8) patent ductus arteriosus (Q25.0) ventricular septal defect (Q21.0)
|
|
| | |
I27.84 |
|
Fontan related circulation |
| |
I27.840 |
|
Fontan-associated liver disease [FALD] |
| | |
I27.841 |
 |
Fontan-associated lymphatic dysfunction |
| |
CodeAlso |
associated conditions such as: chylothorax (J94.0) Fontan associated protein-losing enteropathy (K90.89) plastic (obstructive) bronchitis (J44.89)
|
|
| | |
I27.848 |
 |
Other Fontan-associated condition |
| |
UseAdditionalCode |
code to specify the Fontan associated condition
|
|
| | |
I27.849 |
|
Fontan related circulation, unspecified |
| | | |
I27.89 |
|
Other specified pulmonary heart diseases |
| |
| |
I27.9 |
 |
Pulmonary heart disease, unspecified |
| |
Chronic cardiopulmonary disease |
|
|